abrutinib CAS NO.1622902-68-4
Active Pharmaceutical Ingredients 2025-03-03
| Name | Abrocitinib |
| Synonyms | PF04965842 Abrocitinib ABROCITINIB PF04965842 PF-04965842 PF 04965842 ABROCITINIB PF 04965842 PF-04965842(Abrocitinib) ABROCITINIB (PF-04965842) N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide rel-N-((1s,3s)-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide |
| CAS | 1622902-68-4 |
| Molecular Formula | C14H21N5O2S |
| Molar Mass | 323.41 |
| Density | 1.36±0.1 g/cm3(Predicted) |
| Appearance | powder |
| Color | white to beige |
| pKa | 10.55±0.40(Predicted) |
| Storage Condition | room temp |
| In vivo study | In rats, by intravenous injection of 1 mg/kg or oral administration of 3 mg/kg PF-04965842, its clearance in vivo is low relative to the overall hepatic blood flow, CL = 26.6/min/kg, vdss = 1.04 L/kg,T 1/2=1.1 h. The oral bioavailability was 95.6% PF-04965842. In a rat model of adjuvant arthritis, PF-04965842 had a dose-dependent effect. |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
